AIffinity
@aiffinity.com
AI|ffinity provides NMR-AI drug discovery solutions: 4D-GraFID for protein structure determination up to 30 kDa, deepHitExplorer for fragment screening, and deepScaffOpt for lead optimization. Making the undruggable druggable.
AIffinity's Company Logos
AIffinity's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#072F4E
Tarawera
7, 47, 78
206, 84, 17
91, 40, 0, 69
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#072F4F
Tarawera
7, 47, 79
207, 84, 17
91, 41, 0, 69
About AIffinity
AI|ffinity is a cutting-edge brand specializing in molecular design. Founded in late 2021, AI|ffinity is a spin-off from Masaryk University, supported by the Central European Institute of Technology (CEITEC) in Brno. Our mission is to revolutionize the pharmaceutical and biotechnology industries by harnessing the power of NMR, AI, and Cheminformatics.
We offer a range of innovative services to our clients. Our comprehensive NMR-AI platform covers the entire target-to-lead process, enabling us to quantify protein-ligand binding affinity for hit discovery and lead optimization. We also specialize in characterizing protein-ligand interactions and determining protein 3D structures using state-of-the-art technology.
Our advanced 4D NMR-AI technology is versatile and finds applications in drug design and protein engineering, including nanobody design and biocatalysis. It is distributed to clients as a self-contained Docker image, ensuring easy installation with just a single click.
Operating from our headquarters in Brno-Medlánky, Czech Republic, at JIC INMEC, we are well-positioned to serve our clients. Additionally, we have facilities in Prague's 6 Scott.Weber-Blox. Our long-term vision includes establishing an "NMR hub" in Brno and a "CADD hub" in Prague. With AI|ffinity, expect accelerated drug discovery, increased success rates, and significant cost reduction through cutting-edge technology and strategic integration of drug design and NMR expertise.
